LINDSEY KENNEDY: Open Payments
NPI 1225568934 · BASTIAN, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,793 in 112 payments from 13 companies in 2025. Trend: 2023 $1,472 · 2024 $1,485 · 2025 $1,793
Food & beverage: $1,793
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 19 | $247 |
| Teva Pharmaceuticals USA, Inc. | 15 | $212 |
| E.R. Squibb & Sons, L.L.C. | 13 | $203 |
| Neurocrine BioSciences, Inc. | 11 | $200 |
| Janssen Pharmaceuticals, Inc | 9 | $180 |
| Alkermes, Inc. | 12 | $179 |
| Lundbeck LLC | 11 | $169 |
| Vanda Pharmaceuticals Inc. | 9 | $154 |
| ABBVIE INC. | 5 | $87 |
| Braeburn Inc. | 3 | $70 |
Products named: CAPLYTA, COBENFY, INGREZZA, INVEGA SUSTENNA, ABILIFY MAINTENA, ARISTADA, HETLIOZ, UZEDY.
Industry payments across VA — which companies pay providers there.
